StockData
ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26

Adicet Bio, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.53−0.04 (-0.88%)

Close on Oct 19, 2026

Market cap
$48.68M
P/E (TTM)
–
Dividend yield
–

Adicet Bio, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Adicet Bio does not break out revenue by segment, region or product in the tagged data of its filings for this period type.